Anti-Inflammatory Mechanisms of Phenanthroindolizidine Alkaloids
- 6 December 2005
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Molecular Pharmacology
- Vol. 69 (3), 749-758
- https://doi.org/10.1124/mol.105.017764
Abstract
The molecular mechanisms for the anti-inflammatory activity of phenanthroindolizidine alkaloids were examined in an in vitro system mimicking acute inflammation by studying the suppression of lipopolysaccharide (LPS)/interferon-gamma (IFNgamma)-induced nitric oxide production in RAW264.7 cells. Two of the phenanthroindolizidine alkaloids, NSTP0G01 (tylophorine) and NSTP0G07 (ficuseptine-A), exhibited potent suppression of nitric oxide production and did not show significant cytotoxicity to the LPS/IFNgamma-stimulated RAW264.7 cells, in contrast to their respective cytotoxic effects on cancer cells. Tylophorine was studied further to investigate the responsible mechanisms. It was found to inhibit the induced protein levels of tumor necrosis factor-alpha, inducible nitric-oxide synthase (iNOS), and cyclooxygenase (COX)-II. It also inhibited the activation of murine iNOS and COX-II promoter activity. However, of the two common responsive elements of iNOS and COX-II promoters, nuclear factor-kappaB (NF-kappaB) and adaptor protein (AP)1, only AP1 activation was inhibited by tylophorine in the LPS/IFNgamma-stimulated RAW264.7 cells. Further studies showed that the tylophorine enhanced the phosphorylation of Akt and thus decreased the expression and phosphorylation levels of c-Jun protein, thereby causing the subsequent inhibition of AP1 activity. Furthermore, the tylophorine was able to block mitogen-activated protein/extracellular signal-regulated kinase kinase 1 activity and its downstream signaling activation of NF-kappaB and AP1. Thus, NSTP0G01 exerts its anti-inflammatory effects by inhibiting expression of the proinflammatory factors and related signaling pathways.Keywords
This publication has 36 references indexed in Scilit:
- PI-3K and Akt are mediators of AP-1 induction by 5-MCDE in mouse epidermal Cl41 cellsThe Journal of cell biology, 2004
- Second Messenger Pathways in Pulmonary Host DefenseAnnual Review of Physiology, 2003
- TRAF6 and C‐SRC induce synergistic AP‐1 activation via PI3‐kinase–AKT–JNK pathwayEuropean Journal of Biochemistry, 2003
- Phenanthroindolizidine Alkaloids and Their Cytotoxicity from the Leaves of Ficus septicaHETEROCYCLES, 2002
- Inhibition of cellular immune responses by Tylophora indica in experimental modelsPhytomedicine, 2001
- Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator‐activated receptor‐γ by flavonoids in mouse macrophagesFEBS Letters, 2001
- Herbal medicines for asthma: a systematic reviewThorax, 2000
- Cytotoxic Activity of Some Phenanthroindolizidine N-Oxide Alkaloids from Cynanchum vincetoxicumJournal of Natural Products, 2000
- Analysis of the Cytokine-Stimulated Human Inducible Nitric Oxide Synthase (iNOS) Gene: Characterization of Differences between Human and Mouse iNOS PromotersBiochemical and Biophysical Research Communications, 1998
- Further Investigation of Phenanthroindolizidine Alkaloids from Tylophora tanakae.CHEMICAL & PHARMACEUTICAL BULLETIN, 1998